Boston Scientific Corp. Stock Plummets to New 52-Week Low at USD 58.03

Boston Scientific Corp. has reached a significant milestone by touching a new 52-week low of USD 58.03 on April 28, 2026. This decline marks a notable shift in the stock's performance, reflecting a 24.5% decrease over the past year, contrasting sharply with the S&P 500's gain of 29.12% during the same period. As a large-cap company in the retailing industry, Boston Scientific Corp. holds a market capitalization of approximately USD 121.9 billion. The stock currently has a price-to-earnings (P/E) ratio of 36.00, indicating how investors value the company's earnings relative to its share price. Additionally, the company maintains a debt-to-equity ratio of 0.39, suggesting a relatively low level of debt compared to its equity. Despite the recent price movement, Boston Scientific's return on equity stands at 13.88%, and its price-to-book ratio is 5.03. These metrics provide insight into the company's financial health and market position within the retailing sector.